Research provides new hope for tamoxifen-resistant breast cancer patients.
D000970:Antineoplastic Agents / Q000494:pharmacology*; D018931:Antineoplastic Agents, Hormonal / Q000494:pharmacology; D052117:Benzodioxoles / Q000494:pharmacology*; D001943:Breast Neoplasms / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D019008:Drug Resistance, Neoplasm; D005260:Female; D006801:Humans; D011799:Quinazolines / Q000494:pharmacology*; D013629:Tamoxifen / Q000494:pharmacology; D006113:United Kingdom
D000970:Antineoplastic Agents; D018931:Antineoplastic Agents, Hormonal; D052117:Benzodioxoles; D011799:Quinazolines; D013629:Tamoxifen; C515233:saracatinib